- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Melanoma in New Zealand
Total 2368 results
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
Dermatologic Cooperative Oncology GroupUnknown
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
Parker Institute for Cancer ImmunotherapySeres Therapeutics, Inc.CompletedMetastatic MelanomaUnited States
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbActive, not recruitingMetastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal MelanomaUnited States
-
NewLink Genetics CorporationCompletedMetastatic Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
TransMolecularTerminatedMelanoma | Metastatic Melanoma | Malignant MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
VicalCompletedMetastatic MelanomaUnited States
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Novartis PharmaceuticalsCompletedBRAF v600 Mutated Metastatic MelanomaUnited States
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Delcath Systems Inc.National Cancer Institute (NCI)CompletedMetastatic Cancer | Intraocular Melanoma | Melanoma (Skin)United States
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Hoffmann-La RocheCompletedMetastatic MelanomaUnited States, Canada, Belgium, Spain, France, Russian Federation, Australia
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic MelanomaUnited States
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Idera Pharmaceuticals, Inc.CompletedMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)Memorial Sloan Kettering Cancer Center; Institut Curie Paris; Moffitt Cancer...Active, not recruitingMetastatic Uveal Melanoma | Stage IV Uveal Melanoma AJCC v7United States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Melanoma and Skin Cancer Trials LimitedUniversity of Oxford; Trans Tasman Radiation Oncology GroupActive, not recruitingMetastatic MelanomaNorway, Australia, United Kingdom
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
BiocadRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma AdvancedIndia, Russian Federation, Belarus
-
Piramal Enterprises LimitedCompletedMelanomaAustralia, India, New Zealand